Vincerx Pharma, Inc. (VINC)
NASDAQ: VINC · IEX Real-Time Price · USD
0.870
-0.110 (-11.22%)
At close: Apr 15, 2024, 4:00 PM
0.845
-0.025 (-2.90%)
Pre-market: Apr 16, 2024, 6:30 AM EDT

Vincerx Pharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Selling, General & Admin
13.6418.8922.583.60
Research & Development
28.9749.8440.087.120
Other Operating Expenses
02.47000
Operating Expenses
42.6171.1962.6610.710
Operating Income
-42.61-71.19-62.66-10.71-0
Other Expense / Income
-2.45-8.21-23.355.91-
Pretax Income
-40.16-62.98-39.31-16.62-0
Net Income
-40.16-62.98-39.31-16.62-0
Shares Outstanding (Basic)
21211751
Shares Outstanding (Diluted)
21211751
Shares Change
1.26%22.43%227.04%320.16%-
EPS (Basic)
-1.89-3.00-2.29-3.16-
EPS (Diluted)
-1.89-3.00-2.29-3.16-
Free Cash Flow
-40.45-59.6-38.66-2.280
Free Cash Flow Per Share
-1.90-2.83-2.25-0.43-
EBITDA
-39.24-62.05-38.97-16.62-0
Depreciation & Amortization
0.920.940.3400
EBIT
-40.16-62.98-39.31-16.62-0
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).